Richard Slansky
Finanzdirektor/CFO bei GENENTA SCIENCE S.P.A.
Vermögen: 63 631 $ am 31.05.2024
Profil
Richard B.
Slansky currently works at Genenta Science SpA, as Chief Financial Officer from 2021.
Mr. Slansky also formerly worked at Quick Strike Resources, Inc., as Director, Chief Executive & Financial Officer from 2002 to 2003, Path 1 Network Technologies, Inc., as CFO, Secretary, VP-Administration & Operations from 2000 to 2002, SpaceDev, Inc., as President, Chief Financial Officer & Secretary, Star Equity Holdings, Inc., as Chief Financial Officer & Head-Investor Relations from 2010 to 2012, OncoSec Medical, Inc., as CFO, Secretary & Principal Accounting Officer, GenMark Diagnostics, Inc., as Chief Financial Officer from 2012 to 2014, and Biological Dynamics, Inc., as Chief Financial Officer.
Mr. Slansky received his Masters Business Admin degree from the University of Arizona and undergraduate degree from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GENENTA SCIENCE SPA
0,11% | 26.03.2024 | 19 947 ( 0,11% ) | 63 631 $ | 31.05.2024 |
Aktive Positionen von Richard Slansky
| Unternehmen | Position | Beginn |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Finanzdirektor/CFO | 20.05.2021 |
Ehemalige bekannte Positionen von Richard Slansky
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Finanzdirektor/CFO | 16.07.2018 |
| GENMARK DIAGNOSTICS, INC. | Finanzdirektor/CFO | 13.05.2014 |
| STAR EQUITY HOLDINGS, INC. | Finanzdirektor/CFO | 20.04.2012 |
SpaceDev, Inc.
 SpaceDev, Inc. Aerospace & DefenseElectronic Technology SpaceDev, Inc. develops spacecraft microsats, nanosats and maneuvering and orbital transfer vehicles. The company was founded by James Benson in 1997 and is headquartered in Sparks, NV. | Finanzdirektor/CFO | - |
| Quick Strike Resources, Inc. | Präsident | 01.02.2003 |
Ausbildung von Richard Slansky
| University of Arizona | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| STAR EQUITY HOLDINGS, INC. | Health Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| GENENTA SCIENCE S.P.A. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Path 1 Network Technologies, Inc.
 Path 1 Network Technologies, Inc. Internet Software/ServicesTechnology Services Path 1 Network Technologies, Inc. offers internet protocol video transport products. It is the essential analytics and gateway provider for client IP video network, carrying the valuable content on the demanding networks throughout the world. The company was founded by Ronald D. Fellman and Douglas A. Palmer on January 30, 1998 and is headquartered in San Diego, CA. | Technology Services |
SpaceDev, Inc.
SpaceDev, Inc. Aerospace & DefenseElectronic Technology SpaceDev, Inc. develops spacecraft microsats, nanosats and maneuvering and orbital transfer vehicles. The company was founded by James Benson in 1997 and is headquartered in Sparks, NV. | Electronic Technology |
GenMark Diagnostics, Inc.
 GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA. | Health Technology |
| Quick Strike Resources, Inc. | |
Biological Dynamics, Inc.
 Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | Distribution Services |
